Grants and Contributions:
Title:
Research and Develop Commercial Scale Mycelium Production.
Agreement Number:
1027823
Agreement Value:
$228,168.00
Agreement Date:
Feb 10, 2025 - Mar 20, 2026
Description:
Hire two biologists to develop mycelium strains and commercialization methods. Hire two mycologists and a consultant to work on novel ectomycorrhizal and saprophytic production methods and substrates using underutilized resources. Data and analyses produced will be used to commercialize novel species using novel production techniques outdoors.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
St John's, Newfoundland & Labrador, CA A1E 2A6
Reference Number:
172-2024-2025-Q4-1027823
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
744296617
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 151 days. The total amended value is 92,056 dollars.
Amendment Date
Jun 2, 2025
Recipient's Legal Name:
Nuspora Life Sciences Inc.
Federal Riding Name:
St. John's South--Mount Pearl
Federal Riding Number:
10007
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
111411
Amendments: